Enhanced Provides Clinician-Led Access to Six New Peptides
Business Wire•03/11/2026•08:15 ET
0
Key Highlights
- ➤Six new peptides launched through Live Enhanced, expanding clinician-led offering
- ➤Prescription access begins today following October 28, 2026 HHS policy
- ➤U.S. licensed pharmacies compound peptides using FDA-registered, CGMP-compliant ingredients
- ➤FDA 503A bulk-drug rulemaking continues; advisory committee reviews additional peptides February 2027
Expert Statements
Maximilian Martin, Co-Founder and Chief Executive Officer of Enhanced
“This is a significant step for Live Enhanced and for Enhanced as a company. Our customers have been asking for clinician-led access to these peptides, and we now have the clinical protocols, pharmacy partners and platform to offer it responsibly. It deepens what Live Enhanced offers every member, and it positions us well as the regulatory picture develops. We believe the right way to grow in this category is with medical supervision by licensed clinicians, regulated pharmacies and quality-controlled ingredients,”
Prescription-only access through licensed clinicians and U.S. licensed pharmacies begins today
Quality-tested ingredients, trained prescribing clinicians and defined clinical protocols
Get started
Create a free account to read the full story.